IDYA
IDEAYA Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$31.99
+2.09%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 35.00x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.83x
- Price / sales
- 84.65x
- Price / cash flow
- -8.90x
Enterprise value
- Enterprise value
- $2.0B
- EV / sales
- 53.97x
- EV / EBITDA
- -4.61x
- EV / EBIT
- -4.26x
- Market cap
- $3.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026